Evidence map›Paper›PMID 36633406›Full record

ArticleJournal of virology2023

Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters.

Nozomi Shiwa-Sudo, Yusuke Sakai, Naoko Iwata-Yoshikawa, Shinji Watanabe, Souichi Yamada, Yudai Kuroda, Tsukasa Yamamoto, Masayuki Shirakura, Seiichiro Fujisaki, Kaya Miyazaki and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Viruses · 2025
    Article
  2. Article
  3. Omicron breakthrough infections in vaccinated or previously infected hamsters.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 1 institution in 1 country.

Nozomi Shiwa-SudoDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Yusuke SakaiDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Naoko Iwata-YoshikawaDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Shinji WatanabeResearch Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, Tokyo, Japan.
Souichi YamadaDepartment of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.
Yudai KurodaDepartment of Veterinary Science, National Institute of Infectious Diseases, Tokyo, Japan.
Tsukasa YamamotoDepartment of Veterinary Science, National Institute of Infectious Diseases, Tokyo, Japan.
Masayuki ShirakuraResearch Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, Tokyo, Japan.
Seiichiro FujisakiResearch Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, Tokyo, Japan.
Kaya MiyazakiResearch Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, Tokyo, Japan.
Hideka MiuraResearch Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, Tokyo, Japan.
Shiho NagataResearch Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, Tokyo, Japan.
Shuetsu FukushiDepartment of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.
Ken MaedaDepartment of Veterinary Science, National Institute of Infectious Diseases, Tokyo, Japan.
Hideki HasegawaResearch Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, Tokyo, Japan.
Tadaki SuzukiDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Noriyo NagataDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.ORCID 0000-0001-9147-1438
National Institute of Infectious Diseases · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The diversity of SARS-CoV-2 mutations raises the possibility of reinfection of individuals previously infected with earlier variants, and this risk is further increased by the emergence of the B.1.1.529 Omicron variant. In this study, we used an

Indexed as

COVID-19ReinfectionAnimalsCricetinaeMesocricetusRNA, ViralSARS-CoV-2RNA, Viralanimal modelpathogenesisreinfectionSARS-CoV-2variants

Identifiers

PMID36633406
PMCPMC9888231
OpenAlexW4315754079

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.